Biospace
Published September 14, 2026 · Updated September 15, 2026
Definium moves toward FDA submission for LSD drug in anxiety after 'another clear win'
Read the full story at Biospace
Fifty-two patients received a 50-ug dose—a cohort that “was not designed or powered for statistical comparisons,” per Definium's press release .
Surfaced by 2 Google Alerts
- Psychedelic press release
- Psychedelic biotech
